In addition, PRC2 dysregulation increases HOXC10 expression in KRAS mutant NSCLC, which coordinates with MEK to enhance the expression of E2F1 targets encoding pre-replication complex proteins 109. The gene discussed is MAP2K7; the disease is non-small cell lung carcinoma.